LIFU therapy holds promise as a new treatment strategy for GBM, with the potential to improve patient prognosis.<h4>Conclusions</h4>LIFU suppresses GBM progression through the Piezo1/ATF3/PPP1r15a axis by activating endoplasmic reticulum stress. Here, PPP1R15A is linked to glioblastoma.